New research in Sweden has produced a "blueprint" revealing how the human heart is built during prenatal development. It ...
Over one in 150 births ended in a stillbirth, with a significantly higher rate of one in 112 in low-income areas.
TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback